BACKGROUND: Human milk from the infant's mother (own mother's milk; OMM) feedings reduces the risk of several morbidities in very low birthweight (VLBW) infants, but limited data exist regarding its impact on bronchopulmonary dysplasia (BPD). OBJECTIVE: To prospectively study the impact of OMM received in the neonatal intensive care unit (NICU) on the risk of BPD and associated costs. DESIGN/ METHODS: A 5-year prospective cohort study of the impact of OMM dose on growth, morbidity and NICU costs in VLBW infants. OMM dose was the proportion of enteral intake that consisted of OMM from birth to 36 weeks postmenstrual age (PMA) or discharge, whichever occurred first. BPD was defined as the receipt of oxygen and/or positive pressure ventilation at 36 weeks PMA. NICU costs included hospital and physician costs. RESULTS: The cohort consisted of 254 VLBW infants with mean birth weight 1027±257 g and gestational age 27.8±2.5 weeks. Multivariable logistic regression demonstrated a 9.5% reduction in the odds of BPD for every 10% increase in OMM dose (OR 0.905 (0.824 to 0.995)). After controlling for demographic and clinical factors, BPD was associated with an increase of US$41 929 in NICU costs. CONCLUSIONS: Increased dose of OMM feedings from birth to 36 weeks PMA was associated with a reduction in the odds of BPD in VLBW infants. Thus, high-dose OMM feeding may be an inexpensive, effective strategy to help reduce the risk of this costly multifactorial morbidity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND:Human milk from the infant's mother (own mother's milk; OMM) feedings reduces the risk of several morbidities in very low birthweight (VLBW) infants, but limited data exist regarding its impact on bronchopulmonary dysplasia (BPD). OBJECTIVE: To prospectively study the impact of OMM received in the neonatal intensive care unit (NICU) on the risk of BPD and associated costs. DESIGN/ METHODS: A 5-year prospective cohort study of the impact of OMM dose on growth, morbidity and NICU costs in VLBW infants. OMM dose was the proportion of enteral intake that consisted of OMM from birth to 36 weeks postmenstrual age (PMA) or discharge, whichever occurred first. BPD was defined as the receipt of oxygen and/or positive pressure ventilation at 36 weeks PMA. NICU costs included hospital and physician costs. RESULTS: The cohort consisted of 254 VLBW infants with mean birth weight 1027±257 g and gestational age 27.8±2.5 weeks. Multivariable logistic regression demonstrated a 9.5% reduction in the odds of BPD for every 10% increase in OMM dose (OR 0.905 (0.824 to 0.995)). After controlling for demographic and clinical factors, BPD was associated with an increase of US$41 929 in NICU costs. CONCLUSIONS: Increased dose of OMM feedings from birth to 36 weeks PMA was associated with a reduction in the odds of BPD in VLBW infants. Thus, high-dose OMM feeding may be an inexpensive, effective strategy to help reduce the risk of this costly multifactorial morbidity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Entities:
Keywords:
Neonatology; bronchopulmonary dysplasia; costs; human milk; premature infant
Authors: Amy B Hair; Allison M Peluso; Keli M Hawthorne; Jose Perez; Denise P Smith; Janine Y Khan; Andrea O'Donnell; Richard J Powers; Martin L Lee; Steven A Abrams Journal: Breastfeed Med Date: 2016-01-20 Impact factor: 1.817
Authors: Jessica Liu; Margaret G Parker; Tianyao Lu; Shannon M Conroy; John Oehlert; Henry C Lee; Scarlett Lin Gomez; Salma Shariff-Marco; Jochen Profit Journal: J Pediatr Date: 2019-12-13 Impact factor: 4.406
Authors: Erin Fleurant; Michael Schoeny; Rebecca Hoban; Ifeyinwa V Asiodu; Brittany Riley; Paula P Meier; Harold Bigger; Aloka L Patel Journal: Breastfeed Med Date: 2016-12-01 Impact factor: 1.817
Authors: Andrew Romaine; Reese H Clark; Briana R Davis; Kaitlin Hendershot; Vance Kite; Madeleine Laughon; Isaac Updike; Marie Lynn Miranda; Paula P Meier; Aloka L Patel; P Brian Smith; C Michael Cotten; Daniel K Benjamin; Rachel G Greenberg Journal: J Pediatr Date: 2018-08-28 Impact factor: 4.406
Authors: Kousiki Patra; Matthew Hamilton; Tricia J Johnson; Michelle Greene; Elizabeth Dabrowski; Paula P Meier; Aloka L Patel Journal: Neonatology Date: 2017-08-03 Impact factor: 4.035
Authors: Amrit Kumar Shrestha; Matthew L Bettini; Renuka T Menon; Vashisht Y N Gopal; Shixia Huang; Dean P Edwards; Mohan Pammi; Roberto Barrios; Binoy Shivanna Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-10-11 Impact factor: 5.464